Infosys Limited (NYSE:INFY) is New Vernon Capital Holdings II LLC's 4th Largest Position

New Vernon Capital Holdings II LLC cut its holdings in Infosys Limited (NYSE:INFY - Free Report) by 12.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 601,217 shares of the technology company's stock after selling 86,655 shares during the quarter. Infosys makes up about 7.7% of New Vernon Capital Holdings II LLC's holdings, making the stock its 4th biggest holding. New Vernon Capital Holdings II LLC's holdings in Infosys were worth $13,179,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Sierra Ocean LLC bought a new stake in Infosys in the 4th quarter worth approximately $29,000. Brooklyn Investment Group bought a new position in Infosys in the 4th quarter worth $52,000. Wilmington Savings Fund Society FSB purchased a new stake in Infosys in the 3rd quarter worth $57,000. Farther Finance Advisors LLC raised its position in shares of Infosys by 69.7% during the 4th quarter. Farther Finance Advisors LLC now owns 3,115 shares of the technology company's stock valued at $68,000 after buying an additional 1,279 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Infosys by 14.2% during the 4th quarter. GAMMA Investing LLC now owns 4,496 shares of the technology company's stock valued at $99,000 after buying an additional 560 shares in the last quarter. 16.20% of the stock is owned by hedge funds and other institutional investors.

Infosys Stock Performance

NYSE INFY traded down $0.10 during trading on Wednesday, reaching $17.47. The company's stock had a trading volume of 3,185,795 shares, compared to its average volume of 9,615,231. The firm has a market cap of $72.36 billion, a price-to-earnings ratio of 22.11, a P/E/G ratio of 3.50 and a beta of 0.97. Infosys Limited has a twelve month low of $15.82 and a twelve month high of $23.63. The business's fifty day moving average price is $18.25 and its 200-day moving average price is $20.82.

Infosys (NYSE:INFY - Get Free Report) last issued its earnings results on Thursday, April 17th. The technology company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.01. Infosys had a net margin of 17.28% and a return on equity of 31.60%. The company had revenue of $4.79 billion for the quarter, compared to analyst estimates of $420.69 billion. During the same period in the prior year, the business posted $0.23 earnings per share. As a group, sell-side analysts forecast that Infosys Limited will post 0.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on INFY shares. Susquehanna raised shares of Infosys from a "negative" rating to a "neutral" rating and set a $17.00 price objective on the stock in a research report on Monday, April 14th. Guggenheim reissued a "neutral" rating on shares of Infosys in a research report on Friday, January 17th. CLSA raised Infosys from a "hold" rating to an "outperform" rating in a research report on Friday, March 7th. The Goldman Sachs Group lowered Infosys from a "buy" rating to a "neutral" rating and set a $17.90 target price on the stock. in a research report on Monday, April 21st. Finally, StockNews.com lowered Infosys from a "buy" rating to a "hold" rating in a report on Wednesday, April 23rd. Seven equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Infosys presently has a consensus rating of "Moderate Buy" and a consensus target price of $17.48.

About Infosys

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.